(July 8, 2024, 1:40 PM EDT) -- WASHINGTON, D.C. — The District of Columbia Circuit U.S. Court of Appeals dismissed a petition for review filed by Juul Labs Inc. (JLI) challenging the Food and Drug Administration’s marketing denial order (MDO) issued to JLI in 2022, granting JLI and FDA’s joint motion for dismissal filed after the FDA formally rescinded the MDO to conduct a new review of JLI’s products....